Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-11-27

Clinical Trial Update: A Study to Assess the pharmacoMRI Effects of AUT00206 in Healthy Males [Phase 1]

View source ↗

Summary

Phase 1 study to assess the pharmacoMRI effects of AUT00206 in healthy male volunteers. Schizophrenia is listed as a related condition in the trial documentatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AUT00206

Snippet

Sponsor: Autifony Therapeutics Limited | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED